Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction

This study aimed to investigate the prognostic value of dynamic changes in left ventricular ejection fraction (EF) for cardiovascular (CV) outcomes in an all‐comer heart failure (HF) population with reduced EF (HFrEF, EF < 40%). We sought to identify independent factors related to improvement in EF and to identify risk factors for increased risk of CV events in the subgroups of improved EF (iEF) and non‐improved EF (niEF), respecively.

[1]  Y. Yoon,et al.  Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction , 2021, Scientific Reports.

[2]  S. Solomon,et al.  Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal? , 2021, Current opinion in cardiology.

[3]  D. Mann,et al.  Improvement of ejection fraction and mortality in ischaemic heart failure , 2020, Heart.

[4]  D. Mann,et al.  Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. , 2020, Journal of the American College of Cardiology.

[5]  Akshay S. Desai,et al.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.

[6]  Y. Pinto,et al.  Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction , 2019, Heart.

[7]  G. Gulati,et al.  Heart Failure With Improved Ejection Fraction: Is it Possible to Escape One's Past? , 2018, JACC. Heart failure.

[8]  R. A. Agra Bermejo,et al.  Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. , 2018, Cardiology journal.

[9]  James E. Tcheng,et al.  2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials , 2018, Circulation.

[10]  A. Dunning,et al.  Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block. , 2018, Journal of the American College of Cardiology.

[11]  Anne L. Taylor,et al.  Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial. , 2017, Journal of cardiac failure.

[12]  Akshay S. Desai,et al.  2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. , 2018, Journal of the American College of Cardiology.

[13]  M. de Antonio,et al.  Recovered heart failure with reduced ejection fraction and outcomes: a prospective study , 2017, European journal of heart failure.

[14]  Roland A Matsouaka,et al.  Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.

[15]  K. Anstrom,et al.  Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial , 2017, JAMA.

[16]  M. Guazzi,et al.  Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction , 2017, European journal of heart failure.

[17]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[18]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[19]  Dean Y. Li,et al.  Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. , 2016, Journal of the American College of Cardiology.

[20]  J. Cohn,et al.  Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival Results From the Valsartan Heart Failure Trial , 2016, Circulation. Heart failure.

[21]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[22]  M. Cho,et al.  Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF , 2015, Heart.

[23]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  A. Zwinderman,et al.  Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. , 2014, JACC. Heart failure.

[25]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[26]  Mark Woodward,et al.  Risk prediction in patients with heart failure: a systematic review and analysis. , 2014, JACC. Heart failure.

[27]  D. Mann,et al.  Epidemiology and Natural History of Recovery of Left Ventricular Function in Recent Onset Dilated Cardiomyopathies , 2013, Current Heart Failure Reports.

[28]  Bart Bijnens,et al.  Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease. , 2013, European heart journal cardiovascular Imaging.

[29]  J. G. González Juanatey,et al.  Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. , 2013, Cardiology journal.

[30]  J. Cleland,et al.  Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. , 2012, Journal of cardiac failure.

[31]  C. O'connor,et al.  Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. , 2012, American heart journal.

[32]  Marco Merlo,et al.  Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. , 2011, Journal of the American College of Cardiology.

[33]  M. Cicoira,et al.  Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background , 2011, Cardiology research and practice.

[34]  G. Hillis,et al.  Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta‐analysis of longitudinal data (MeRGE Heart Failure) , 2009, European journal of heart failure.

[35]  Miguel Ventura,et al.  Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[36]  N. Lamblin,et al.  The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. , 2007, American heart journal.

[37]  Einar Heiberg,et al.  The quantitative relationship between longitudinal and radial function in left, right, and total heart pumping in humans. , 2007, American journal of physiology. Heart and circulatory physiology.

[38]  B. Sveälv,et al.  Ventricular long-axis function is of major importance for long-term survival in patients with heart failure , 2007, Heart.

[39]  Peter C Austin,et al.  Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.

[40]  L. Tavazzi,et al.  Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 2000, The American journal of cardiology.

[41]  D G Gibson,et al.  Normal long axis function , 1999, Heart.